Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
09 2020
Historique:
received: 11 11 2019
revised: 19 05 2020
accepted: 08 06 2020
pubmed: 11 7 2020
medline: 23 7 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

To investigate oncological outcomes and relapse patterns in retroperitoneal lymph node (LN)-only recurrences with salvage retroperitoneal lymph node dissection (S-RPLND). We reviewed records of 19 patients undergoing RPLND for RCC recurrences between 2011 and 2018. All patients initially had primary non-metastatic RCC, with subsequent recurrence restricted to the retroperitoneal lymph nodes (LN). LN recurrence sites after nephrectomy and relapses after S-RPLND were assessed. The primary outcomes were post-RPLND Relapse-Free Survival (RFS), and Cancer-Specific Survival (CSS). The median age of our cohort was 60 years at RPLND. Right and left nephrectomies were performed in 14 (73.7%) and 5 (26.3%), respectively. Clear cell carcinoma was found in 10 (52.6%) patients, followed by papillary in 4(21.1%), chromophobe in 2(10.5%), and 'other' in 3 (15.8%). The extent of lymphadenectomy during nephrectomy and S-RPLND varied based on surgical approach. The median follow-up time after S-RPLND of the entire cohort was 31.53 months, and the median RFS was 9.63 months. Overall, 4 patients died of cancer, of which 3 (75%) were N1 at time of nephrectomy. The CSS after RPLND at 3 and 5 years was 81.5% and 61.1%, respectively. The RFS after RPLND at 2 and 5 years was 44.4% and 29.6%, respectively. Our results suggest that aggressive surgical management provides satisfactory CSS with acceptable complication rates. Moreover, we believe this subset of patients with node-only recurrence showed an unpredictable pattern of lymphatic spread, with predilection for regional dissemination warranting surgical resection of LN recurrences in a bilateral template fashion when feasible.

Identifiants

pubmed: 32646691
pii: S1078-1439(20)30274-X
doi: 10.1016/j.urolonc.2020.06.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

739.e1-739.e8

Informations de copyright

Published by Elsevier Inc.

Auteurs

Marcelo P Barboza (MP)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana.

Ryan W Speir (RW)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana. Electronic address: rwspeir@iu.edu.

Ronald S Boris (RS)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana.

Adam C Calaway (AC)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana.

Clint Cary (C)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana.

Richard S Foster (RS)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana.

Timothy A Masterson (TA)

Indiana University School of Medicine, Department of Urology, Indianapolis, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH